Treatment of dyskinetic and dystonic disorders with CF 25-397: clinical and pharmacological aspects.
D000368:Aged; D002230:Carbidopa / Q000627:therapeutic use; D004421:Dystonia / Q000188:drug therapy*; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D006527:Hepatolenticular Degeneration / Q000188:drug therapy; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000188:drug therapy*; D010300:Parkinson Disease / Q000188:drug therapy
D004873:Ergolines; D007980:Levodopa; C012145:CF 25397; D002230:Carbidopa